Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Intermolecular Inc.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 26.91M 42.67M 53.52M 66.83M 67.41M
Cost of Goods Sold (COGS) incl. D&A 13.02M 20.93M 25.47M 28.4M 32.49M
COGS excluding D&A 8.64M 15.96M 18.39M 20.4M 23.09M
Depreciation & Amortization Expense 4.38M 4.97M 7.08M 8M 9.4M
Depreciation 4.38M 4.96M 7M 7.41M 8.78M
Amortization of Intangibles 5,000 9,000 81,000 588,000 615,000
Gross Income 13.89M 21.75M 28.05M 38.42M 34.92M
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 19.06M 23.75M 32.05M 38.14M 42.95M
Research & Development 10.98M 13.92M 19.26M 21.84M 24.5M
Other SG&A 8.08M 9.84M 12.79M 16.3M 18.45M
Other Operating Expense 0 0 0 0 0
Unusual Expense 0 0 26.18M 0 0
EBIT after Unusual Expense 0 0 (26.18M) 0 0
Non Operating Income/Expense (62,000) 202,000 298,000 15,000 57,000
Non-Operating Interest Income - 43,000 0 0 0
Equity in Affiliates (Pretax) 0 0 0 0 -
Interest Expense 6,000 0 87,000 1M 830,000
Gross Interest Expense 6,000 0 87,000 1M 830,000
Interest Capitalized - 0 0 0 0
Pretax Income (5.24M) (1.76M) (29.97M) (705,000) (8.8M)
Income Tax 17,000 19,000 43,000 51,000 17,000
Income Tax - Current Domestic 4,000 1,000 1,000 1,000 1,000
Income Tax - Current Foreign 13,000 18,000 42,000 50,000 16,000
Income Tax - Deferred Domestic 0 0 0 0 0
Income Tax - Deferred Foreign 0 0 0 0 0
Income Tax Credits 0 0 0 0 0
Equity in Affiliates 0 0 0 0 -
Other After Tax Income (Expense) (9.17M) (14.16M) (8.66M) 0 0
Consolidated Net Income (14.42M) (15.94M) (38.68M) (756,000) (8.82M)
Minority Interest Expense 0 0 - 0 0
Net Income (14.42M) (15.94M) (38.68M) (756,000) (8.82M)
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 - 0 0
Net Income After Extraordinaries (14.42M) (15.94M) (38.68M) (756,000) (8.82M)
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (14.42M) (15.94M) (38.68M) (756,000) (8.82M)
EPS (Basic) (0.44) (0.49) (3.99) (0.02) (0.20)
Basic Shares Outstanding 32.69M 32.69M 9.7M 42.97M 44.96M
EPS (Diluted) (0.44) (0.49) (3.99) (0.02) (0.20)
Diluted Shares Outstanding 32.69M 32.69M 9.7M 42.97M 44.96M
EBITDA (789,000) 2.97M 3.08M 8.28M 1.37M
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.